期刊文献+

氯吡格雷对小鼠小肠黏膜的损伤及其机制研究 被引量:1

Intestinal mucosal injury induced by Clopidogrel in mice and its mechanism
下载PDF
导出
摘要 目的初探氯吡格雷对小鼠小肠黏膜的损伤及可能的机制。方法 20只无特定病原体(SPF)级BALB/c雄性小鼠,随机分为2组:空白对照组、氯吡格雷组,空白对照组灌服生理盐水,氯吡格雷组灌服氯吡格雷,2周后处死小鼠,观察小鼠小肠黏膜大体变化及组织学变化,免疫组织化学(简称免疫组化)法检测小肠黏膜组织中Occludin蛋白的表达情况。结果氯吡格雷组小鼠小肠黏膜大体损伤、组织病理学损伤高于空白对照组(P<0.05);免疫组化测得氯吡格雷组小鼠小肠黏膜Occludin蛋白表达低于空白对照组(P<0.05)。结论氯吡格雷可造成小鼠小肠黏膜损伤;可能通过降低Occludin蛋白表达造成小肠黏膜损伤。 Objective To investigate intestinal mucosal injury induced by Clopidogrel in mice and potential molecular mechanism.Method Twenty SPF grade BALB/C male mice were randomly divided into control group and Clopidogrel group.Mice in Clopidogrel group were treated with Clopidogrel while mice in control group was fed with normal saline.Mice were sacrificed after 2 weeks.Macroscopic and histological changes of the small intestinal mucosa in the two groups were recorded.Expression of Occludin in small intestinal mucosa was determined by immunohistochemistry.Results The macroscopic damage and the histopathologic damage of small intestinal mucosa in Clopidogrel group were significantly higher than those in control group(P<0.05).The expression of Occludin protein in small intestinal mucosa was decreased significantly with treatment of Clopidogrel compared with control group(P<0.05).Conclusions Clopidogrel induces small intestinal mucosa damage through reduction of Occludin expression and inhibition of the repair of small intestinal mucosal injury.
作者 黎敏 丁瑞峰 马晓莹 刘宇超 Min Li;Rui-feng Ding;Xiao-ying Ma;Yu-chao Liu(Department of Gastroenterology,the First Hospital Affiliated of General Hospital of Baotou Medical College,Baotou,Neimenggu 014010,China)
出处 《中国现代医学杂志》 CAS 2018年第21期10-14,共5页 China Journal of Modern Medicine
基金 内蒙古自治区自然科学基金(No:2015MS0861)
关键词 氯吡格雷 OCCLUDIN蛋白 小肠黏膜 损伤 Clopidogrel Occludin protein small intestinal mucosal injury
  • 相关文献

参考文献4

二级参考文献42

  • 1Cappell MS, Schein JR. Diagnosis and treatment of nonsteroidal anti-inflammatory drug associated upper gastrointestinal toxicity. Gastroenterol Clin North Am, 2000, 29,97-124.
  • 2Berkes J, Viswanathan VK, Savkovic SD, et al. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut, 2003, 52:439-451.
  • 3Schneeberger EE, Lynch RD. The tight junction: multifunctional complex. Am J Physiol Cell Physiol, 2004, 286:C1213-C1228.
  • 4Chen YH, Lu Q, Goodenough DA, et ai. Nonreceptor tyrosine kinase c-Yes interacts with occludin during tight junction formation in canine kidney epithelial cells. Mol Biol Cell, 2002,13:1227-1237.
  • 5Thiefin G, Beaugerie L. Toxic effects of nonsteroidai antiinflammatory drugs on the small bowel, colon, and rectum. Joint Bone Spine, 2005, 72:286-294.
  • 6Durand-Zaleski I, Bertrand M. The value of clopidogrel versus aspirin in reducing atherothrombotic events: the CAPRIE study. Pharmacoeconomics 2004; 22 Suppl 4: 19-27.
  • 7Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502.
  • 8Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527-533.
  • 9Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288: 2411-2420.
  • 10Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, Rumsfeld JS. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009; 301: 937-944.

共引文献21

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部